A detailed history of Cornerstone Planning Group LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 110 shares of PRTA stock, worth $1,923. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 27 307.41%
Holding current value
$1,923
Previous $535,000 275.89%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$16.73 - $24.79 $1,388 - $2,057
83 Added 307.41%
110 $2.01 Million
Q2 2024

Aug 13, 2024

BUY
$19.54 - $26.15 $527 - $706
27 New
27 $535,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $821M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.